FYERS
Jenburkt Pharmaceuticals956.80
-1.50 (-0.16%)

Jenburkt Pharmaceuticals Share Price

956.80-1.50 (-0.16%)
-9.48% past 1 Year

Corporate filings & documents

Announcements

Intimation regarding admission of Equity shares of the Company under " Permitted to trade" category on National Stock Exchange of India Limited.
2 days ago
Intimation regarding admission of Equity shares of the Company under " Permitted to trade" category on National Stock Exchange of India Limited.
2 days ago
Intimation of closure of trading window of the Jenburkt Pharmaceuticals Limited as per the SEBI(Prohibition of Insider Trading) Regulations 2015.
2 days ago
Intimation of closure of trading window of the Jenburkt Pharmaceuticals Limited as per the SEBI(Prohibition of Insider Trading) Regulations 2015.
2 days ago
Intimation about Resignation of a Senior Management Personnel of the Company.
6 days ago
Intimation about Resignation of a Senior Management Personnel of the Company.
6 days ago
Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April 2027 to 31st March 2032 Approved with requisite mejority by the shareholders at 41st AGM of the Company held today i.e. 04th September 2026.
2 weeks ago
Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April 2027 to 31st March 2032 Approved with requisite mejority by the shareholders at 41st AGM of the Company held today i.e. 04th September 2026.
2 weeks ago
Submission of consolidated Voting Results and Scrutinizers Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the Company held on 04th September 2026.
2 weeks ago
Submission of consolidated Voting Results and Scrutinizers Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the Company held on 04th September 2026.
2 weeks ago
Proceedings of the 41st Annual General Meeting of the Company held on Friday 04th September 2026.
2 weeks ago
Proceedings of the 41st Annual General Meeting of the Company held on Friday 04th September 2026.
2 weeks ago
Summary of the proceedings of the 41st Annual General Meeting of the Company held on Friday 04th September 2026.
2 weeks ago
Summary of the proceedings of the 41st Annual General Meeting of the Company held on Friday 04th September 2026.
2 weeks ago
Pursuant to Regulation 30 Read with Schedule III of the SEBI(Listing Obligations and Disclosure Requirnments ) Regulations 2015 we hereby inform you about the change in Senior Manaaement personnel of the Company.
2 weeks ago
Pursuant to Regulation 30 Read with Schedule III of the SEBI(Listing Obligations and Disclosure Requirnments ) Regulations 2015 we hereby inform you about the change in Senior Manaaement personnel of the Company.
2 weeks ago
Newspaper Publication for standalone Unaudited Financial Results for the quarter ended on 30th June 2026.
1 month ago
Newspaper Publication for standalone Unaudited Financial Results for the quarter ended on 30th June 2026.
1 month ago
Standalone Unaudited Financial Results for the quarter ended on 30th June 2026.
1 month ago
Standalone Unaudited Financial Results for the quarter ended on 30th June 2026.
1 month ago
Outcome of the Board Meeting held today on 06th August 2026.
1 month ago
Outcome of the Board Meeting held today on 06th August 2026.
1 month ago
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are enclosing herewith clippings of the Newspaper publication for Notice of the 41st AGM of the Company.
1 month ago
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are enclosing herewith clippings of the Newspaper publication for Notice of the 41st AGM of the Company.
1 month ago
Notice of the 41st Annual General Meeting of the Company Schedule to be held on Friday 04th September 2026 through VC/OAVM.
1 month ago
Notice of the 41st Annual General Meeting of the Company Schedule to be held on Friday 04th September 2026 through VC/OAVM.
1 month ago
Submission of the Annual Report for the FY 2025-26 containing Audited Standalone Financial Statements Auditors Report and Directors Report and the Notice convening 41st Annual General Meeting of the Company.
1 month ago
Submission of the Annual Report for the FY 2025-26 containing Audited Standalone Financial Statements Auditors Report and Directors Report and the Notice convening 41st Annual General Meeting of the Company.
1 month ago
Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve standalone unaudited financial results for the quarter ended on 30th June 2026.
1 month ago
Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve standalone unaudited financial results for the quarter ended on 30th June 2026.
1 month ago
Intimation of shifting of Registered Office of the Company within the local limits of city of Mumbai.
2 months ago
Intimation of shifting of Registered Office of the Company within the local limits of city of Mumbai.
2 months ago
Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended on 30th June 2026
2 months ago
Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended on 30th June 2026
2 months ago
Intimation of Closure of Trading Window of Jenburkt Pharmaceuticals Limited as per SEBI(Prohibition of Insider Trading) Regulations 2015.
3 months ago
Intimation of Closure of Trading Window of Jenburkt Pharmaceuticals Limited as per SEBI(Prohibition of Insider Trading) Regulations 2015.
3 months ago
Newspaper Advertisement for giving notice for the purpose of transfer of unclaimed dividend and corresponding equity shares of the Company to IEPFA.
4 months ago
Annual Secretraial Compliance Report for the financial year ended 31st March 2026.
4 months ago
The Company has fixed Friday 28th August 2026 as the Record date for the Payment of Dividend for the Financial Year 2025-26 as well as cut-off date for Remote e-voting and e-voting during the 41st AGM.
4 months ago
Newspaper Publication for standalone Audited financial results for the quarter and financial year ended on 31st March 2026.
4 months ago
Newspaper Publication for standalone Audited financial results for the quarter and financial year ended on 31st March 2026.
4 months ago
The Board of Director of the Company recommeded a dividend of Rs.20.70 (207%) per equity share of Rs.10/- each on 4413300 equity shares of the Company for the financial year 2025-26 Subject to the approval of the menbers it the ensuing 41st AGM of the Company.
4 months ago
The Board of Director of the Company recommeded a dividend of Rs.20.70 (207%) per equity share of Rs.10/- each on 4413300 equity shares of the Company for the financial year 2025-26 Subject to the approval of the menbers it the ensuing 41st AGM of the Company.
4 months ago
Re-appointment of Whole Time Director and CFO of the Company subject to the approval of the members at the ensuing 41st Annual General meeting of the Company.
4 months ago
Re-appointment of Whole Time Director and CFO of the Company subject to the approval of the members at the ensuing 41st Annual General meeting of the Company.
4 months ago
Standalone audited financial reults of the Company for the quarter and financial year ended on 31st March 2026.
4 months ago
Outcome of Board Meeting Held on 05th May 2026.
4 months ago
Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 inter alia to consider and approve the audited results for the quarter and financial year ended on 31st March 2026 and to consider recommendation of dividend if any.
4 months ago
Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 inter alia to consider and approve the audited results for the quarter and financial year ended on 31st March 2026 and to consider recommendation of dividend if any.
4 months ago
Pursuant to SEBI Circular dated 10th August 2021 we hereby confirm that for the financial year ended 31st March 2026 Jenburkt pharmaceuticals Limited is "not a large corporate" as per applicability criteria mentioned in clause 2.11 of chapter XII therein.
5 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Jenburkt Pharmaceuticals Ltd Share Price Today

The Jenburkt Pharmaceuticals Ltd share price today is ₹1055.50. During the trading session, the Jenburkt Pharmaceuticals Ltd share price opened at ₹1022.20 and recorded an intraday high of ₹1057.00 and a low of ₹1022.20. Last closing price was ₹1038.80. Over the past 52 weeks, the Jenburkt Pharmaceuticals Ltd share price has ranged between ₹1010.00 and ₹1073.90. The current Jenburkt Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.